Corey Manley Biography and Net Worth

Executive Vice President, Chief Legal and Administrative Officer of Omnicell

Corey Manley joined Omnicell in April 2021. As Executive Vice President, Chief Legal and Administrative Officer. He has oversight for Omnicell’s global Legal, Compliance, Privacy, Risk, Corporate Responsibility, and EHS (Environmental, Health & Safety) organizations. Mr. Manley also serves as Omnicell’s Corporate Secretary and Chief Compliance Officer. He has more than 20 years of experience as a trusted legal and business advisor to industry-leading global technology and healthcare technology companies. Prior to Omnicell, he was Chief Legal Officer, Corporate Secretary, and Chief Compliance Officer with a global fintech company. Mr. Manley was also a Partner in the law firms of Kirkland & Ellis and Duane Morris. Before attending law school, he worked as an engineer at Motorola. Mr. Manley holds a JD from the University of Notre Dame Law School and a Bachelor of Science degree in Mechanical Engineering from Purdue University.

What is Corey J. Manley's net worth?: The estimated net worth of Corey J. Manley is at least $4.01 million as of March 16th, 2026. Mr. Manley owns 96,717 shares of Omnicell stock worth more than $4,006,018 as of May 1st. This net worth evaluation does not reflect any other assets that Mr. Manley may own. Learn More about Corey J. Manley's net worth.
How do I contact Corey J. Manley?: The corporate mailing address for Mr. Manley and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at [email protected]. Learn More on Corey J. Manley's contact information.
Has Corey J. Manley been buying or selling shares of Omnicell?: Corey J. Manley has not been actively trading shares of Omnicell during the past quarter. Most recently, Corey J. Manley sold 7,405 shares of the business's stock in a transaction on Monday, March 16th. The shares were sold at an average price of $34.69, for a transaction totalling $256,879.45. Following the completion of the sale, the executive vice president now directly owns 96,717 shares of the company's stock, valued at $3,355,112.73. Learn More on Corey J. Manley's trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Joanne Bauer (Director), Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Corey Manley (Executive Vice President, Chief Legal and Administrative Officer), Christine Mellon (EVP), Mark Parrish (Director), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, insiders at the sold shares 3 times. They sold a total of 17,391 shares worth more than $690,578.85. The most recent insider tranaction occured on March, 16th when EVP Corey J Manley sold 7,405 shares worth more than $256,879.45. Insiders at Omnicell own 2.9% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 3/16/2026.

Corey J. Manley Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2026	Sell	7,405	$34.69	$256,879.45	96,717
1/8/2026	Sell	6,106	$49.90	$304,689.40	91,674
9/12/2025	Sell	3,880	$33.25	$129,010.00	110,653

Corey J. Manley Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $41.42

$41.12

$43.91

50 Day Range

MA: $37.16

$32.35

$45.51

2 Week Range

Now: $41.42

$22.66

$55.00

Volume

1,106,640 shs

Average Volume

524,061 shs

Market Capitalization

$1.88 billion

P/E Ratio

94.14

Dividend Yield

N/A

Beta

0.85